905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I
0 activities
A Retrospective Database Analysis of Healthcare Resource Utilization in Patients with Warm Autoimmune Hemolytic Anemia in the United States
1 activities
A Retrospective Database Analysis of Healthcare Resource Utilization in Patients with Warm Autoimmune Hemolytic Anemia in the United States
Baseline Characteristics of Individuals with Paroxysmal Nocturnal Hemoglobinuria in an App-Based Home-Reported Outcomes Study to Evaluate Disease Burden
1 activities
Baseline Characteristics of Individuals with Paroxysmal Nocturnal Hemoglobinuria in an App-Based Home-Reported Outcomes Study to Evaluate Disease Burden
Clinical Characteristic Outcomes and Mortality Among Cancer and Non-Cancer Patients Presented with Incidental Pulmonary Embolism
1 activities
Clinical Characteristic Outcomes and Mortality Among Cancer and Non-Cancer Patients Presented with Incidental Pulmonary Embolism
Co-Morbidities Associated with Depression and Anxiety in Older Patients with Hemophilia
1 activities
Co-Morbidities Associated with Depression and Anxiety in Older Patients with Hemophilia
Complementary and Alternative Medicine (CAM) Use Reported Among Individuals with Immune Thrombocytopenia (ITP): Data from the ITP Natural History Study Registry
1 activities
Complementary and Alternative Medicine (CAM) Use Reported Among Individuals with Immune Thrombocytopenia (ITP): Data from the ITP Natural History Study Registry
Disease Burden of Idiopathic and Lymphocytic Hypereosinophilic Syndrome in the United States: Evidence from a Real-World Retrospective Study of De-Identified Electronic Health Records and Insurance Claims
1 activities
Disease Burden of Idiopathic and Lymphocytic Hypereosinophilic Syndrome in the United States: Evidence from a Real-World Retrospective Study of De-Identified Electronic Health Records and Insurance Claims
Disparities in the Diagnostic Evaluation of Asymptomatic “Neutropenia” and Identification of Duffy-Null Phenotype
1 activities
Disparities in the Diagnostic Evaluation of Asymptomatic “Neutropenia” and Identification of Duffy-Null Phenotype
Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database
1 activities
Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database
Physical and Psychological Burden on People with Hemophilia: Global Real-World Data
1 activities
Physical and Psychological Burden on People with Hemophilia: Global Real-World Data
Practice Patterns and Clinical Outcomes of Thromboprophylaxis during Pregnancy
1 activities
Practice Patterns and Clinical Outcomes of Thromboprophylaxis during Pregnancy
Predictors of in-Hospital Mortality in Thrombotic Thrombocytopenic Purpura in Adults in the United States: A Population Analysis Using the NIS Database
1 activities
Predictors of in-Hospital Mortality in Thrombotic Thrombocytopenic Purpura in Adults in the United States: A Population Analysis Using the NIS Database
Real-World Use of Efanesoctocog Alfa in Adult Patients with Hemophilia a Including Those with a History of Factor VIII Inhibitor
1 activities
Real-World Use of Efanesoctocog Alfa in Adult Patients with Hemophilia a Including Those with a History of Factor VIII Inhibitor
Risk of Hematologic Malignancies in Patients with Acute Myocardial Infarction: A Nationwide Population-Based Cohort Study
1 activities
Risk of Hematologic Malignancies in Patients with Acute Myocardial Infarction: A Nationwide Population-Based Cohort Study
The Association of Anemia and Patient Reported Outcomes in the New Era of PNH Treatment
1 activities
The Association of Anemia and Patient Reported Outcomes in the New Era of PNH Treatment
Unmet Needs in People with Hemophilia Receiving Prophylaxis Treatment: A Real-World Survey
1 activities
Unmet Needs in People with Hemophilia Receiving Prophylaxis Treatment: A Real-World Survey
Use of Calcineurin Inhibitor (CNI) and Eltrombopag (EPAG) Among Patients with Acquired Aplastic Anemia (AA) in the United States: Results from a Large National Database
1 activities
Use of Calcineurin Inhibitor (CNI) and Eltrombopag (EPAG) Among Patients with Acquired Aplastic Anemia (AA) in the United States: Results from a Large National Database